Announces retirement of five directors
BIRMINGHAM, Ala., March 31,
2022 /PRNewswire/ -- Encompass Health Corporation
(NYSE: EHC) today announced the appointment of Kevin J. O'Connor to the Encompass Health Board
of Directors.
In addition, for some time, its Nominating/Corporate Governance
Committee has been focused on crafting an orderly and gradual plan
for director succession and refreshment. In connection with
Encompass Health's previously announced Board refreshment process,
the Company announced that five directors, Yvonne M. Curl, Charles
M. Elson, Leo I. Higdon, Jr.,
John E. Maupin, Jr., and L.
Edward Shaw, Jr., will be retiring
from its Board at this year's annual meeting of stockholders and
will not stand for re-election. Accordingly, following the 2022
annual meeting of stockholders, the Encompass Health Board will be
comprised of 11 directors, 10 of whom will be independent and five
of whom will have been appointed in the last three years, bringing
a broad mix of skills, perspectives, experience, tenure and
diversity to promote and support the Company's long-term
strategy.
Mr. O'Connor joins the Encompass Health Board with significant
experience in compliance, regulatory and governmental affairs
matters and risk management. Mr. O'Connor currently serves as
senior vice president, chief legal officer of Carrier Global
Corporation, a leading global provider of healthy, safe and
sustainable building and cold chain solutions. He also brings
healthcare experience having chaired the board of Trinity Health of
New England, an integrated healthcare system. Prior to joining
Carrier in 2020, he served as chief legal officer of Point72 Asset
Management. He has also held a number of roles in the U.S.
Department of Justice and the U.S. Securities and Exchange
Commission.
"We are pleased that Kevin, an extremely accomplished and
respected executive, will bring a wide and diverse range of skills
and experiences to our Board," said Leo I.
Higdon Jr., chairman of Encompass Health's Board of
Directors. "The appointment of Kevin reflects our commitment to
maintaining a strong board and the Company's position as the
leading provider of post-acute healthcare services in a rapidly
changing healthcare environment."
"I am excited to join the Encompass Health Board and help
advance the Company's commitment to delivering high-quality,
cost-effective integrated care," said Mr. O'Connor. "The Company is
a recognized leader in the healthcare industry."
Mark J. Tarr, president, chief
executive officer and a member of the Board, commented: "On behalf
of the Board and the Company, I would like to thank Lee, Yvonne,
Charles, John and Ed for their many years of distinguished and
valuable service on the Encompass Board. Their many contributions,
including agreeing to extend their terms to help us recruit and
transition to an excellent slate of new directors, have helped to
position the Company for continuing success and value
creation."
About Encompass Health
As a national leader in integrated healthcare services, Encompass
Health (NYSE: EHC) offers both facility–based and home–based
patient care through its network of inpatient rehabilitation
hospitals, home health agencies and hospice agencies. With a
national footprint that includes 147 hospitals, 251 home health
locations, and 96 hospice locations in 42 states and Puerto Rico, the Company provides
high–quality, cost-effective integrated healthcare. Encompass
Health is ranked as one of Fortune's 100 Best Companies to Work
For. For more information, visit encompasshealth.com, or follow us
on our newsroom, Twitter, Instagram and Facebook.
Forward-Looking Statements
Statements
contained in this press release which are not historical facts,
including the future size of the Board of Directors and the
prospects of the Company, are forward-looking statements. In
addition, Encompass Health may from time to time make
forward-looking public statements concerning the matters described
herein. All such estimates, projections, and forward-looking
information speak only as of the date hereof, and Encompass Health
undertakes no duty to publicly update or revise such
forward-looking information, whether as a result of new
information, future events, or otherwise. Such forward-looking
statements are necessarily estimates based upon current information
and involve a number of risks and uncertainties. Encompass Health's
actual results or events may differ materially from those
anticipated in these forward-looking statements as a result of a
variety of factors. While it is impossible to identify all such
factors, factors which could cause actual results or events to
differ materially from those anticipated include, but are not
limited to, any adverse outcome of various lawsuits, claims,
and legal or regulatory proceedings that may be brought by or
against the Company; the possibility a project will experience
unexpected problems or delays; the expected benefits and costs
of Encompass Health's previously announced spin-off
transaction; the expected timing of the completion of the spin-off
transaction and the transaction terms, and the possibility that
Encompass Health may decide not to undertake the spin-off or any
separation transaction or that it is not able to consummate the
spin-off or other separation transaction or the related rebranding
due to, among other things, market, regulatory and other factors;
the potential for disruption to Encompass Health's business
resulting from the undertaking of any transactions or rebranding;
the effect of the transaction and the rebranding on Encompass
Heath's ability to retain and hire key personnel and maintain
relationships with its referral sources and suppliers; adverse
conditions in the healthcare services industry, including any
effects associated with the COVID-19 or other pandemic;
general conditions in the economy and capital markets; and those
factors which may be identified from time to time in Encompass
Health's SEC filings and other public announcements, including
Encompass Health's current reports on Form 8-K, quarterly reports
on Form 10-Q and its latest annual report on Form 10-K for the year
ended December 31, 2021.
Media Contact
Erin
Wendel-Ritter | 205
970-5912
erin.wendel-ritter@encompasshealth.com
Investor Relations Contact
Mark Miller | 205 970-5860
mark.miller@encompasshealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/encompass-health-appoints-kevin-oconnor-to-its-board-of-directors-301514811.html
SOURCE Encompass Health Corp.